ERBB2 and breast carcinoma: To further evaluate the pathway maps and molecular and cellular functions of the genes down-regulated by TAT-NLS-BLBD-6, IPA software was used to identify the top two pathways as IL-9 (p = 2.4E–02, 11.8%) and HER-2 signaling in breast cancer (p = 3.76E–02, 7.9%).